Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Vote in favor of your Number one Sort of Cap - 2Ford Is Using a Chinese-Built Van to Fight Europe’s EV Price War
- 3Feeling wonder every day improves our health. Here’s how to do it.
- 4Exploring the School Application Cycle: Understudy Bits of knowledge
- 5This Week In Space podcast: Episode 186 — Snow on the Moon?
- Kendall Jenner addresses long-standing rumor about her sexuality
- Jason Kelce opens about wife Kylie Kelce's past pregnancy loss
- 5 Great Youngster Care Administrations To Watch in 2024
- Modern surgery began with saws and iron hands – how amputation transformed the body in the Renaissance
- Artemis 2 moon astronauts will try to recreate Apollo 8's historic 'Earthrise' photo during April 6 flyby
- NAFFIC and Aware to Launch First China-Europe Digital Product Passport
- Machado ‘presented’ her Nobel Peace Prize medal to Trump
- The most effective method to Quick Track Your Outcome in Advanced Showcasing with a Web-based Degree
- Investigating Inside Plan and Home Style: Change Your Residing Space
